The pilot will be the first U.S.-based long-term study to test unsupervised daily and overnight use of an artificial pancreas system that-when coupled with mealtime bolusing-automatically controls insulin delivery and keeps blood glucose within a specific range. It will enroll up to 48 adults with T1D to test the system over an 11- to 14-week period. Participants will be asked to use the experimental system (which combines a
The forthcoming studies and the developing system are part of work being conducted under the JDRF Artificial Pancreas Program's worldwide consortium of researchers. The consortium is committed to advancing the delivery of fully automated, 24-hour artificial pancreas systems that are able to keep blood-glucose levels within a specific range with little to no user intervention. If the
Keywords for this news article include: JDRF, Pancreas, Proinsulin, Technology, Gastroenterology, Peptide Hormones.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- Prosecutor to Investigate Walmart Police Shooting
- GM to Announce New Jobs in Tennessee
- Smith & Wesson Misses Target
- Emirates Hit Libyan Targets With Airstrikes
- Mark Sanchez Suddenly a Hot QB Commodity
- Michael Brown Funeral: Can Americans Change the Script of Violence?
- Marco Rubio Warns Obama on Deportations
- American Killed With ISIS Fighters in Syria
- Surf's Up! SoCal Prepares for Big Storm Surf
- Hamas Claims Gaza Ceasefire as Victory Over Israel